John J Mason
Examiner (ID: 6497)
Most Active Art Unit | 2198 |
Art Unit(s) | 2198 |
Total Applications | 1 |
Issued Applications | 1 |
Pending Applications | 0 |
Abandoned Applications | 0 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7677719
[patent_doc_number] => 20040152107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Gene signature of electroshock therapy and methods of use'
[patent_app_type] => new
[patent_app_number] => 10/664705
[patent_app_country] => US
[patent_app_date] => 2003-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 31657
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152107.pdf
[firstpage_image] =>[orig_patent_app_number] => 10664705
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/664705 | Gene signature of electroshock therapy and methods of use | Sep 17, 2003 | Abandoned |
Array
(
[id] => 894540
[patent_doc_number] => 07341832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-03-11
[patent_title] => 'Genes involved in neuropsychiatric disorders'
[patent_app_type] => utility
[patent_app_number] => 10/649400
[patent_app_country] => US
[patent_app_date] => 2003-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 8
[patent_no_of_words] => 27489
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/341/07341832.pdf
[firstpage_image] =>[orig_patent_app_number] => 10649400
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/649400 | Genes involved in neuropsychiatric disorders | Aug 25, 2003 | Issued |
Array
(
[id] => 7220742
[patent_doc_number] => 20040072275
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Interaction of NMDA receptor with protein tyrosine phosphatase'
[patent_app_type] => new
[patent_app_number] => 10/633109
[patent_app_country] => US
[patent_app_date] => 2003-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12656
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20040072275.pdf
[firstpage_image] =>[orig_patent_app_number] => 10633109
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/633109 | Interaction of NMDA receptor with protein tyrosine phosphatase | Jul 31, 2003 | Abandoned |
Array
(
[id] => 7672742
[patent_doc_number] => 20040181037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-16
[patent_title] => 'Phosphatidyl serine receptors and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/625492
[patent_app_country] => US
[patent_app_date] => 2003-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 36660
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20040181037.pdf
[firstpage_image] =>[orig_patent_app_number] => 10625492
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/625492 | Phosphatidyl serine receptors and uses thereof | Jul 21, 2003 | Abandoned |
Array
(
[id] => 7395058
[patent_doc_number] => 20040018151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Use of anandamide/cannabinoid receptor/acceptor agonists in als screening and treatment methods'
[patent_app_type] => new
[patent_app_number] => 10/624199
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 3553
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20040018151.pdf
[firstpage_image] =>[orig_patent_app_number] => 10624199
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/624199 | Use of anandamide/cannabinoid receptor/acceptor agonists in als screening and treatment methods | Jul 20, 2003 | Abandoned |
Array
(
[id] => 7364306
[patent_doc_number] => 20040091945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Peptides and methods of screening immunogenic peptide vaccines against Alzheimer\'s Disease'
[patent_app_type] => new
[patent_app_number] => 10/619454
[patent_app_country] => US
[patent_app_date] => 2003-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14802
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20040091945.pdf
[firstpage_image] =>[orig_patent_app_number] => 10619454
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/619454 | Peptides and methods of screening immunogenic peptide vaccines against Alzheimer's Disease | Jul 15, 2003 | Abandoned |
Array
(
[id] => 7230190
[patent_doc_number] => 20040156841
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-12
[patent_title] => 'Human amine transporter'
[patent_app_type] => new
[patent_app_number] => 10/619485
[patent_app_country] => US
[patent_app_date] => 2003-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11778
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20040156841.pdf
[firstpage_image] =>[orig_patent_app_number] => 10619485
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/619485 | Human amine transporter | Jul 15, 2003 | Abandoned |
Array
(
[id] => 7364957
[patent_doc_number] => 20040005661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-08
[patent_title] => 'Potential growth factors from the human tumour cell line ht 1080'
[patent_app_type] => new
[patent_app_number] => 10/344503
[patent_app_country] => US
[patent_app_date] => 2003-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 15134
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0005/20040005661.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344503
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344503 | Potential growth factors from the human tumour cell line ht 1080 | Jul 7, 2003 | Abandoned |
Array
(
[id] => 7247293
[patent_doc_number] => 20050272093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/613744
[patent_app_country] => US
[patent_app_date] => 2003-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 36474
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272093.pdf
[firstpage_image] =>[orig_patent_app_number] => 10613744
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/613744 | Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof | Jul 2, 2003 | Abandoned |
Array
(
[id] => 7395538
[patent_doc_number] => 20040018199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-01-29
[patent_title] => 'Compositions and methods of use for an ephrin receptor'
[patent_app_type] => new
[patent_app_number] => 10/449569
[patent_app_country] => US
[patent_app_date] => 2003-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 47202
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0018/20040018199.pdf
[firstpage_image] =>[orig_patent_app_number] => 10449569
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/449569 | Compositions and methods of use for an ephrin receptor | May 28, 2003 | Abandoned |
Array
(
[id] => 6796867
[patent_doc_number] => 20030175741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-18
[patent_title] => 'Schizophrenia related gene'
[patent_app_type] => new
[patent_app_number] => 10/240154
[patent_app_country] => US
[patent_app_date] => 2003-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 10234
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 33
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0175/20030175741.pdf
[firstpage_image] =>[orig_patent_app_number] => 10240154
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/240154 | Schizophrenia related gene | Apr 28, 2003 | Abandoned |
Array
(
[id] => 7286943
[patent_doc_number] => 20040146945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Olfactory neuron cultures and method of making and using the same'
[patent_app_type] => new
[patent_app_number] => 10/422005
[patent_app_country] => US
[patent_app_date] => 2003-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 6113
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146945.pdf
[firstpage_image] =>[orig_patent_app_number] => 10422005
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/422005 | Olfactory neuron cultures and method of making and using the same | Apr 22, 2003 | Abandoned |
Array
(
[id] => 6968872
[patent_doc_number] => 20050235365
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-20
[patent_title] => 'Helicokinin-receptor from insects'
[patent_app_type] => utility
[patent_app_number] => 10/511221
[patent_app_country] => US
[patent_app_date] => 2003-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6984
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20050235365.pdf
[firstpage_image] =>[orig_patent_app_number] => 10511221
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/511221 | Helicokinin-receptor from insects | Apr 3, 2003 | Abandoned |
Array
(
[id] => 6953074
[patent_doc_number] => 20050228169
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-10-13
[patent_title] => 'Polypeptide binding to human syntaxin 1a'
[patent_app_type] => utility
[patent_app_number] => 10/508190
[patent_app_country] => US
[patent_app_date] => 2003-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12732
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0228/20050228169.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508190
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508190 | Polypeptide binding to human syntaxin 1a | Mar 18, 2003 | Abandoned |
Array
(
[id] => 7394054
[patent_doc_number] => 20040038343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'G-protein coupled receptors'
[patent_app_type] => new
[patent_app_number] => 10/363481
[patent_app_country] => US
[patent_app_date] => 2003-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40038
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10363481
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/363481 | G-protein coupled receptors | Feb 26, 2003 | Abandoned |
Array
(
[id] => 7464779
[patent_doc_number] => 20040166535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-26
[patent_title] => 'Method fo assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters'
[patent_app_type] => new
[patent_app_number] => 10/374288
[patent_app_country] => US
[patent_app_date] => 2003-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4600
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20040166535.pdf
[firstpage_image] =>[orig_patent_app_number] => 10374288
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/374288 | Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters | Feb 24, 2003 | Issued |
Array
(
[id] => 7467490
[patent_doc_number] => 20040053826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Uses of polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/344381
[patent_app_country] => US
[patent_app_date] => 2003-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 80355
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053826.pdf
[firstpage_image] =>[orig_patent_app_number] => 10344381
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/344381 | Uses of polypeptides | Feb 5, 2003 | Abandoned |
Array
(
[id] => 6769847
[patent_doc_number] => 20030215787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-20
[patent_title] => 'Modulators of the CLC-7 chloride channel and methods for their identification and use in the treatment and prevention of osteoporosis and related disease states'
[patent_app_type] => new
[patent_app_number] => 10/349670
[patent_app_country] => US
[patent_app_date] => 2003-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8573
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20030215787.pdf
[firstpage_image] =>[orig_patent_app_number] => 10349670
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/349670 | Modulators of the CLC-7 chloride channel and methods for their identification and use in the treatment and prevention of osteoporosis and related disease states | Jan 22, 2003 | Abandoned |
10/332721 | C1Q-related factor, homologous polypeptides and therapeutic uses thereof | Jan 8, 2003 | Abandoned |
Array
(
[id] => 6822079
[patent_doc_number] => 20030220240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Vesicle trafficking proteins'
[patent_app_type] => new
[patent_app_number] => 10/168659
[patent_app_country] => US
[patent_app_date] => 2002-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38489
[patent_no_of_claims] => 122
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20030220240.pdf
[firstpage_image] =>[orig_patent_app_number] => 10168659
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/168659 | Vesicle trafficking proteins | Dec 26, 2002 | Abandoned |